EBIT: Income before interest and taxes.
Evofem Biosciences, Inc. (EVFM) had EBIT of $3.35M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$9.56M |
|
$2.79M |
|
$2.59M |
|
$6.97M |
|
$6.22M |
|
$3.35M |
|
$-0.56M |
|
$2.79M |
|
$2.79M |
|
$2.79M |
|
$2.79M |
|
$2.79M |
|
$2.79M |
|
|
EBIT |
$3.35M |
$3.45M |
|
123.66M |
|
6.42B |
|
$0.02 |
|
$0.03 |
|
| Balance Sheet Financials | |
$15.28M |
|
$0.42M |
|
$4.99M |
|
$20.27M |
|
$84.82M |
|
-- |
|
$4.89M |
|
$89.71M |
|
$-74.34M |
|
$-73.78M |
|
$-69.44M |
|
126.69M |
|
| Cash Flow Statement Financials | |
$-1.99M |
|
$-0.06M |
|
$1.89M |
|
$0.74M |
|
$0.58M |
|
$-0.16M |
|
$0.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.18 |
|
-- |
|
-- |
|
-- |
|
-0.78 |
|
72.89% |
|
34.99% |
|
34.99% |
|
-- |
|
29.15% |
|
29.14% |
|
$-2.05M |
|
-- |
|
-- |
|
-- |
|
0.47 |
|
2.30 |
|
0.77 |
|
117.48 |
|
-3.75% |
|
-3.78% |
|
13.75% |
|
-4.02% |
|
$-0.55 |
|
$-0.00 |
|
$-0.00 |
|